342 related articles for article (PubMed ID: 30041252)
1. Comparison of the Efficacy of Sub-Tenon versus Intravitreal Triamcinolone Acetonide Injection during Cataract Surgery for Diabetic Macular Edema.
Tatsumi T; Oshitari T; Ando T; Takatsuna Y; Arai M; Baba T; Sato E; Yamamoto S
Ophthalmologica; 2019; 241(1):17-23. PubMed ID: 30041252
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intravitreal preservative-free triamcinolone versus posterior sub-tenon triamcinolone acetonide injection for bevacizumab-resistant diabetic macular edema.
Jeon SH; Kim M; Roh YJ
BMC Ophthalmol; 2024 Jan; 24(1):25. PubMed ID: 38243166
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.
Yilmaz T; Weaver CD; Gallagher MJ; Cordero-Coma M; Cervantes-Castaneda RA; Klisovic D; Lavaque AJ; Larson RJ
Ophthalmology; 2009 May; 116(5):902-11; quiz 912-3. PubMed ID: 19410949
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal versus subtenon triamcinolone acetonide injection for diabetic macular edema: a systematic review and meta-analysis.
Qi HP; Bi S; Wei SQ; Cui H; Zhao JB
Curr Eye Res; 2012 Dec; 37(12):1136-47. PubMed ID: 22793880
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal versus sub-tenon posterior triamcinolone injection in bilateral diffuse diabetic macular edema.
Yalcinbayir O; Gelisken O; Kaderli B; Avci R
Ophthalmologica; 2011; 225(4):222-7. PubMed ID: 21389739
[TBL] [Abstract][Full Text] [Related]
8. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
Yu SY; Nam DH; Lee DY
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
[TBL] [Abstract][Full Text] [Related]
9. Short-Term Results of Intravitreal Triamcinolone Acetonide Combined with Cataract Surgery for Diabetic Macular Edema in Japan: In the Era of Anti-Vascular Endothelial Growth Factor Therapy.
Nunome T; Sugimoto M; Kondo M; Suto C
Ophthalmologica; 2018; 240(2):73-80. PubMed ID: 29621780
[TBL] [Abstract][Full Text] [Related]
10. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
Batioğlu F; Ozmert E; Parmak N; Celik S
Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
[TBL] [Abstract][Full Text] [Related]
11. The effects of intravitreal triamcinolone acetonide in diabetic macular edema refractory to anti-VEGF treatment.
Hong IH; Choi W; Han JR
Jpn J Ophthalmol; 2020 Mar; 64(2):196-202. PubMed ID: 31900869
[TBL] [Abstract][Full Text] [Related]
12. Phase II/III Clinical Trial of Sub-Tenon Injection of Triamcinolone Acetonide (WP-0508ST) for Diabetic Macular Edema.
Ogura Y; Shimura M; Iida T; Sakamoto T; Yoshimura N; Yamada M; Ishibashi T
Ophthalmologica; 2019; 241(3):161-169. PubMed ID: 30176671
[TBL] [Abstract][Full Text] [Related]
13. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
[TBL] [Abstract][Full Text] [Related]
14. Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema.
Shimura M; Yasuda K; Minezaki T; Noma H
Jpn J Ophthalmol; 2016 Sep; 60(5):401-7. PubMed ID: 27306783
[TBL] [Abstract][Full Text] [Related]
15. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
Lee HY; Lee SY; Park JS
Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
[TBL] [Abstract][Full Text] [Related]
16. Flare levels after intravitreal injection of ranibizumab, aflibercept, or triamcinolone acetonide for diabetic macular edema.
Morioka M; Takamura Y; Yamada Y; Matsumura T; Gozawa M; Inatani M
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2301-2307. PubMed ID: 30238189
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.
Song JH; Lee JJ; Lee SJ
Korean J Ophthalmol; 2011 Jun; 25(3):156-60. PubMed ID: 21655039
[TBL] [Abstract][Full Text] [Related]
18. The role of macular hydration in the evaluation of the effect of intravitreal triamcinolone on visual acuity in eyes with diabetic macular edema.
Sonmez K; Tezel TH; Kaplan HJ
Int Ophthalmol; 2013 Feb; 33(1):15-25. PubMed ID: 22890369
[TBL] [Abstract][Full Text] [Related]
19. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
[TBL] [Abstract][Full Text] [Related]
20. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
